ARNOLD & PORTER KAYE SCHOLER LLP for RECORDATI RARE DISEASES INC.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.
Foreign entity interest: Recordati Rare Diseases Inc. is ultimately owned by Recordati Industria Chimica e Farmaceutica S.p.A., which may have an interest in the lobbying activity disclosed herein.
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTORIA DAVILA | — |
| PETER ERIC DUYSHART | — |
| BOBBY MCMILLIN | — |
| EUGENIA PIERSON | — |
Health Issues HCR
Issues related to improving access to needed therapies for rare and ultra-rare diseases in the United States. Issues related to drug pricing, including most favored nation (MFN) policies.
Foreign entity interest: Recordati Rare Diseases Inc. is ultimately owned by Recordati Industria Chimica e Farmaceutica S.p.A., which may have an interest in the lobbying activity disclosed herein.
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTORIA DAVILA | — |
| PETER ERIC DUYSHART | — |
| BOBBY MCMILLIN | — |
| EUGENIA PIERSON | — |
Trade (domestic/foreign) TRD
Issues related to trade and tariff policies pertaining to therapies for rare and ultra-rare diseases in the United States.
Foreign entity interest: Recordati Rare Diseases Inc. is ultimately owned by Recordati Industria Chimica e Farmaceutica S.p.A., which may have an interest in the lobbying activity disclosed herein.
| Lobbyist | Covered position, as disclosed |
|---|---|
| VICTORIA DAVILA | — |
| PETER ERIC DUYSHART | — |
| BOBBY MCMILLIN | — |
| EUGENIA PIERSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.